ORIC peer analysis
Oric (ORIC) against its competitors: price, today's move, 1-year return and market value side by side.
ORIC and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AVBP ArriVent BioPharma | $13.40 | 0.37% | -28.46% | – |
| CRVS Corvus Pharmaceuticals | $9.70 | -3.29% | 20.65% | $843.73M |
| ELVN Enliven Therapeutics | $44.63 | 0.86% | 90.56% | – |
| JANX Janux | $17.46 | -0.06% | -39.18% | – |
| MGNX MacroGenics | $2.33 | -2.92% | 40.36% | $152.88M |
| NUVB Nuvation Bio | $4.59 | -3.57% | -12.07% | – |
| NVCT Nuvectis Pharma | $19.18 | 3.79% | 185.84% | – |
| SNDX Syndax Pharmaceuticals | $13.25 | 1.15% | -3.28% | $1.22B |
| TYRA Tyra Biosciences | $21.33 | 1.23% | 34.66% | – |
| VSTM Verastem | $9.59 | -1.64% | 1.48% | $1.18B |
| ORIC Oric | $9.07 | -1.84% | -31.08% | $957.75M |
- ORIC's peers: AVBP (ArriVent BioPharma), CRVS (Corvus Pharmaceuticals), ELVN (Enliven Therapeutics), JANX (Janux), MGNX (MacroGenics), NUVB (Nuvation Bio), NVCT (Nuvectis Pharma), SNDX (Syndax Pharmaceuticals).
Updated 2026-11-03 12:33 UTC